2020 ASCO Virtual Direct™ Highlights

 

Head&Neck
11:18

2020 ASCO Virtual Direct™ Highlights

ASCO 2020 Updates on De-Intensification for Head&Neck Cancers: Is Weekly Cisplatin Inferior to High Dose Cisplatin? Should We Start Reducing RT Doses in HPV+ Disease?

FEATURING Jessica Bauman
  • 116 views
  • September 18, 2020
  • 1
08:42

2020 ASCO Virtual Direct™ Highlights

ASCO 2020 Updates on IO in H&N Cancers: Cetuximab + Nivo, Cetuximab + Monalizumab, Pembro + ICOS Agonist: How Do They Affect Clinical Activities and Is ORR Improved?

FEATURING Jessica Bauman
  • 9 views
  • September 18, 2020
08:59

2020 ASCO Virtual Direct™ Highlights

ASCO 2020 Update on H&N Cancers: Are PFS and OS Prolonged With Tipifarnib?

FEATURING Jessica Bauman
  • 231 views
  • September 18, 2020
  • 1